A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis | ||
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Harvard University. Harvard School of Public Health | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Massachusetts General Hospital | |
| dc.conicet.organizacion | Mercury Pharmaceuticals | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Mercury Pharmaceuticals | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Bioquímicas de La Plata "Prof. Dr. Rodolfo R. Brenner". Universidad Nacional de la Plata. Facultad de Ciencias Médicas. Instituto de Investigaciones Bioquímicas de La Plata "Prof. Dr. Rodolfo R. Brenner" | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Massachusetts General Hospital | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | Mercury Pharmaceuticals | |
| dc.conicet.organizacion | Harvard Medical School | |
| dc.conicet.organizacion | King’s College London | |
| dc.conicet.organizacion | The Broad Institute | |
| dc.contributor.author | Zadra, Giorgia | |
| dc.contributor.author | Photopoulos, Cornelia | |
| dc.contributor.author | Tyekucheva, Svitlana | |
| dc.contributor.author | Heidari, Pedram | |
| dc.contributor.author | Weng, Qing Ping | |
| dc.contributor.author | Fedele, Giuseppe | |
| dc.contributor.author | Liu, Hong | |
| dc.contributor.author | Scaglia, Natalia | |
| dc.contributor.author | Priolo, Carmen | |
| dc.contributor.author | Sicinska, Ewa | |
| dc.contributor.author | Mahmood, Umar | |
| dc.contributor.author | Signoretti, Sabina | |
| dc.contributor.author | Birnberg, Neal | |
| dc.contributor.author | Loda, Massimo | |
| dc.date.issued | 2014-02 | |
| dc.description.abstract | 5´AMP-activated kinase (AMPK) constitutes a hub for cellular metabolic and growth control, thus representing an ideal therapeutic target for prostate cancers (PCas) characterized by increased lipogenesis and activation of mTORC1 pathway. However, whether AMPK activation itself is sufficient to block cancer cell growth remains to be determined. A small molecule screening was performed and identified MT 63-78, a specific and potent direct AMPK activator. Here, we show that direct activation of AMPK inhibits PCa cell growth in androgen sensitive and castration resistant PCa (CRPC) models, induces mitotic arrest, and apoptosis. In vivo, AMPK activation is sufficient to reduce PCa growth, whereas the allelic loss of its catalytic subunits fosters PCa development. Importantly, despite mTORC1 blockade, the suppression of de novo lipogenesis is the underpinning mechanism responsible for AMPK-mediated PCa growth inhibition, suggesting AMPK as a therapeutic target especially for lipogenesis-driven PCas. Finally, we demonstrate that MT 63-78 enhances the growth inhibitory effect of AR signaling inhibitors MDV3100 and abiraterone. This study thus provides a rationale for their combined use in CRPC treatment. | es |
| dc.description.fil | Fil: Zadra, Giorgia. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Photopoulos, Cornelia. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Tyekucheva, Svitlana. Harvard University. Harvard School of Public Health; Estados Unidos. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Heidari, Pedram. Massachusetts General Hospital; Estados Unidos | |
| dc.description.fil | Fil: Weng, Qing Ping. Mercury Pharmaceuticals; Estados Unidos | |
| dc.description.fil | Fil: Fedele, Giuseppe. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Liu, Hong. Mercury Pharmaceuticals; Estados Unidos | |
| dc.description.fil | Fil: Scaglia, Natalia. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Bioquímicas de La Plata "Prof. Dr. Rodolfo R. Brenner". Universidad Nacional de la Plata. Facultad de Ciencias Médicas. Instituto de Investigaciones Bioquímicas de La Plata "Prof. Dr. Rodolfo R. Brenner"; Argentina. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Priolo, Carmen. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Sicinska, Ewa. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Mahmood, Umar. Massachusetts General Hospital; Estados Unidos | |
| dc.description.fil | Fil: Signoretti, Sabina. Harvard Medical School; Estados Unidos | |
| dc.description.fil | Fil: Birnberg, Neal. Mercury Pharmaceuticals; Estados Unidos | |
| dc.description.fil | Fil: Loda, Massimo. Harvard Medical School; Estados Unidos. King’s College London; Reino Unido. The Broad Institute; Estados Unidos | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Zadra, Giorgia; Photopoulos, Cornelia; Tyekucheva, Svitlana; Heidari, Pedram; Weng, Qing Ping; et al.; A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis; Wiley Blackwell Publishing, Inc; Embo Molecular Medicine; 6; 4; 2-2014; 519-538 | es |
| dc.identifier.eissn | 1757-4684 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 1757-4676 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/101867 | |
| dc.journal.ciudad | Londres | es |
| dc.journal.number | 4 | es |
| dc.journal.pagination | 519-538 | es |
| dc.journal.pais | Reino Unido | es |
| dc.journal.title | Embo Molecular Medicine | es |
| dc.journal.volume | 6 | es |
| dc.language.iso | eng | es |
| dc.publisher | Wiley Blackwell Publishing, Inc | es |
| dc.relation | Corregido en https://doi.org/10.15252/emmm.201470070 | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/emmm.201302734 | |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/url/https://www.embopress.org/doi/full/10.1002/emmm.201302734 | |
| dc.rights | info:eu-repo/semantics/openAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by/2.5/ar/ | * |
| dc.subject | AMPK DIRECT ACTIVATION | es |
| dc.subject | ANDROGEN SIGNALING INHIBITORS | es |
| dc.subject | DE NOVO LIPOGENESIS | es |
| dc.subject | PROSTATE CANCER | es |
| dc.subject.classification | Bioquímica y Biología Molecular | es |
| dc.subject.classification | Ciencias Biológicas | es |
| dc.subject.classification | CIENCIAS NATURALES Y EXACTAS | es |
| dc.title | A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.3045e167-cb82-4044-a5ef-b77f6122bad1_A.pdf
- Tamaño:
- 2.68 MB
- Formato:
- Adobe Portable Document Format